Dopeso et al. reported that the DNA repair factor Aprataxin (APTX) regulates the response to the Topo I inhibitor irinotecan in metastatic colorectal cancer, with lower protein expression associated with a longer survival period [35]. Here, APTX is linked to metastatic colorectal cancer.